Glenmede Trust CO Na Bicycle Therapeutics PLC Call Options Transaction History
Glenmede Trust CO Na
- $18.2 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BCYC
# of Institutions
117Shares Held
42MCall Options Held
111KPut Options Held
16.6K-
Baker Bros. Advisors LP New York, NY10.9MShares$79 Million0.77% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.45MShares$25.1 Million6.5% of portfolio
-
Armistice Capital, LLC New York, NY2.8MShares$20.3 Million0.34% of portfolio
-
Westfield Capital Management CO LP Boston, MA2.66MShares$19.3 Million0.12% of portfolio
-
Siren, L.L.C. New York, NY2.01MShares$14.6 Million0.72% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $215M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...